Aramark Burn Gel
FDA Label NDC 81238-5000

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Western First Aid Safety Dba Aramark for the product Aramark Burn Gel (NDC 81238-5000). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, active ingredients, purpose, uses, warnings, otc - keep out of reach of children, do not use, stop use and ask a doctor if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Other

Drug Facts

Active Ingredients

Lidocaine HCL 2.0%

Purpose

Topical pain relief

Uses

Temporary pain relief for minor burns. For

professional use only.

Warnings

For external use only.

Otc - Keep Out Of Reach Of Children

If swallowed, get medical help or contact a Poison Control Center directly.

Do Not Use

  • in large quantities, particularly over raw or blistered areas
  • near eyes, if tgis happenr rinse thoroughly with water

Stop Use And Ask A Doctor If

• the condition worsens or symptoms persist for more

than 7 days or clear up and occur again within a few days

Directions

• Adults and children 2 years of age and older:

apply to affected area not more than 3 to 4 times daily

• Children under 2 years: do not use, consult a doctor

Other Information

• store at room temperature (do not freeze)

• do not use any open or torn packets

Inactive Ingredients

aloe vera, carbomer, germaben II, menthol,

propylene glycol, purified water, triethanolamine,

vitamin E acetate

Questions Od Comments?

1-800-456-7077

Package Labeling

aramark

25 ct. Each Packet Net. Wt. 0.9g

BURN GEL
For Temporary Pain Relief of Minor Burns

aramarkuniform.com

MANUFACTURED FOR:
Aramark
Lenexa, KS 66219 

886-362-2691

Please retain carton for drug information.

res

* Please review the disclaimer below.